Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

Also called NCT07807423

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Volta Medical (from the registry)
Registry
  • NCT NCT07807423
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07807423. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-09-22 (actual); primary completion 2028-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.
Acronym
DISPLAY-AF
Intervention (Device)
Complete biatrial mapping
Lead sponsor
Volta Medical (class: industry)

Record details

Record id
cardio:ct-nct07807423
Content hash
11d470b948ed0f7c8edce77e5d2e07d72b0a995cda84d4ad2fd24e5688aec6cd